PDF herunterladen
CC BY 4.0 · Surg J (N Y) 2017; 03(01): e23-e24
DOI: 10.1055/s-0037-1599072
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Simultaneous Incidental Parathyroid Carcinoma and Intrathyroid Parathyroid Gland in Suspected Renal Failure Induced Hyperparathyroidism

Andrew Pappa
1   Department of Otolaryngology - Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
,
Trevor Hackman
1   Department of Otolaryngology - Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
› Institutsangaben
Weitere Informationen

Publikationsverlauf

16. September 2016

09. Januar 2017

Publikationsdatum:
28. Februar 2017 (online)

   Lizenzen und Reprints

Abstract

Hyperparathyroidism is a common disorder affecting more than hundreds of thousands of people annually. While most commonly secondary to an adenoma, it may also arise from four-gland hyperplasia or malignancy. In the case of primary hyperparathyroidism, the number of glands involved may be unknown prior to surgery. In contrast, the metabolic disorder associated with renal failure induced hyperparathyroidism ensures a hyperplasia picture. Despite the uniform hyperplasia seen in tertiary disease and the preoperative expectation for four-gland exploration, our case demonstrates the continued need for a surgeon's vigilance during dissection to identify all glands and appropriately use intraoperative parathyroid hormone (PTH) testing. In addition, while intraoperative PTH assessment is an effective method for confirming adequacy of treatment for hyperparathyroidism, only surgical pathology can confirm malignancy, which should be considered with PTH levels > 1,000. The case also underscores the importance of comprehensive surgery management and mindful interpretation of intraoperative PTH levels in the management of hyperparathyroidism. Standard surgical technique includes complete exploration of the central compartment, and thyroid lobectomy when the aforementioned exploration fails to reveal the necessary parathyroid tissue, especially with a persistently elevated PTH. Without a standardized progressive compartment exploration and judicious use of intraoperative hormone testing, intrathyroidal parathyroid glands can be missed.

Keywords

tertiary hyperparathyroidism - parathyroid cancer - intrathryoidal parathyroid - intraoperative PTH - parathyroidectomy
 

  • References

  • 1 Kearns AE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc 2002; 77 (01) 87-91
    CrossrefPubMedGoogle Scholar
  • 2 Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol 2012; 13 (01) 11-23
    CrossrefPubMedGoogle Scholar
  • 3 Goodman A, Politz D, Lopez J, Norman J. Intrathyroid parathyroid adenoma: incidence and location--the case against thyroid lobectomy. Otolaryngol Head Neck Surg 2011; 144 (06) 867-871
    CrossrefPubMedGoogle Scholar
  • 4 Bae JH, Choi HJ, Lee Y. , et al. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism. J Korean Med Sci 2012; 27 (08) 890-895
    CrossrefPubMedGoogle Scholar
  • 5 Rajaei MH, Bentz AM, Schneider DF, Sippel RS, Chen H, Oltmann SC. Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol 2015; 22 (02) 454-459
    CrossrefPubMedGoogle Scholar